Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-10

FDA Approved: HEPARIN SODIUM — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira's supplemental application for Heparin Sodium, updating the product's approval details.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

SUPPL AP for HEPARIN SODIUM (HEPARIN SODIUM)